Periosteal Ewing's sarcoma treated by photodynamic therapy with acridine orange

Oncology Reports

Volumn 13, Issue 2, 2005, Pages 279-282

  Yoshida, Kakunoshin ^a   Kusuzaki, Katsuyuki ^a   Matsubara, Takao ^a   Matsumine, Akihiko ^a   Kumamoto, Tadashi ^a   Komada, Yoshihiro ^a   Naka, Norifumi ^b   Uchida, Atsumasa ^a  

^a MIE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

Author keywords

Acridine orange; Periosteal Ewing's sarcoma; Photodynamic therapy

Indexed keywords

ACRIDINE ORANGE;

ARTICLE; BONE TUMOR; CASE REPORT; CHILD; EWING SARCOMA; HUMAN; HUMERUS; MALE; METHODOLOGY; PERIOSTEUM; PHOTOCHEMOTHERAPY;

ACRIDINE ORANGE; BONE NEOPLASMS; CHILD; HUMANS; HUMERUS; MALE; PERIOSTEUM; PHOTOCHEMOTHERAPY; SARCOMA, EWING'S;

EID: 16244423352     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Bator SM, Bauer TW, Marks KE and Norris DG: Periosteal Ewing's Sarcoma. Cancer 58: 1781-1784, 1986. (Pubitemid 16032165)
2. Shapeero LG, Vancl D, Sundaram M, Ackerman LV, Wuisman P, Bauer TW, Neuenschwander S, Contesso G, Janney C, McDonald DJ and Gcnin J: Periosteal Ewing's Sarcoma. Radiology 191: 825-831, 1994.
3. Wuisman P, Roessner A, Blasius S, Erlemann, Winkelmann W and Ritter J: (Sub)periosteal Ewing's sarcoma of bone. J Cancer Res Clin Oncol 118:72-74, 1992.
4. Hatori M, Okada K. Nishida J and Kokubunn S: Periosteal Ewing's sarcoma. Arch Orthop Trauma Surg 121: 594-597, 2001
5. Bacci G, Forni C, Longhi A, Ferrari S, Donati D, Paolis M, Barieri E, Pignotti E. Rosito P and Versari M: Long-term outcome for patients with non-metastatic Ewing's sarcoma treated with adjuvant and neoadjuvant chemotherapies. 402 patients treated at Rizzoli between 1972 and 1992. Eur J Cancer 40: 73-83, 2004. (Pubitemid 37542320)
6. Kolb EA, Kushner BH, Gorlick R, Laverdiere C, Healey JH, LaQuaglia MP, Huvos AG, Qin J, Vu HT, Wexlerr L, Wolden S and Meyers PA: Long-term event-free survival after intensive chemotherapy for Ewing's family of tumors in children and young adults. J Clin Oncol 21: 3423-3430, 2003. (Pubitemid 46594075)
7. Kusuzaki K, Suginoshita T, Minami G, Aomori K. Takeshita H, Murata H, Hashiguchi S, Ashihara T and Hirasawa Y: Fluorovisualization effect of acridine orange on mouse osteosarcoma. Anticancer Res 20: 3019-3024, 2000.
8. Kusuzaki K, Minami G, Takeshita H, Murata H, Hashiguchi S, Nozaki T, Ashihara T and Hirasawa Y: Photodynamic inactivation with acridine orange on a multidrug-resistant mouse osteosarcoma cell line. Jpn J Cancer Res 91: 439-445, 2000. (Pubitemid 30312697)
9. Kusuzaki K, Aomori, K. Suginoshita, T, Minami G, Takeshita H, Murata H, Hashiguchi S, Ashihara T and Hirasawa Y: Total tumor cell elimination with minimum damage to normal tissues in musculoskeletal sarcomas by photodynamic reaction with acridine orange. Oncology 59: 174-180, 2000.
10. Hashiguchi S, KusuzakfK, Murata H, Takeshita H, Hashiba M, Nishimura T, Ashihara T and Hirasawa Y: Acridine orange excited by low-dose radiation has a strong cytocidal effect on mouse osteosarcoma. Oncology 62: 85-93, 2002. (Pubitemid 34124230)
11. Weiss SW and Goldblum JR: Enzinger and Weiss's soft tissue tumors, 4th edition. Mosby, St. Louis, 2001.
12. Kusuzaki K, Malsubara T, Okamura A, Okuyama N, Seto M, Matsumine A and Uchida A: Clinical outcome of photodynamic and radiodynamic therapy with acridine orange for reduction surgery in musculoskeletal sarcomas. Proceedings of the 25th annual meeting. Photommed Pholobiol 25: 9, 2003.